Monthlyupdate - Central & peripheral nervous systems: Pharmacotherapeutic potential for compounds acting at NMDA receptors: Update 1995

Medicine & Life Sciences

• eliprodil 100%
• selfotel 92%
• Peripheral Nervous System 76%
• N-Methyl-D-Aspartate Receptors 70%
• Glutamic Acid 61%
• tirilazad 59%
• N-Methylaspartate 57%
• Central Nervous System 52%
• Traumatic Brain Injury 51%
• Stroke 36%
• lubeluzole 33%
• Nootropic Agents 24%
• Excitatory Amino Acids 22%
• Glutamate Receptors 19%
• Second Messenger Systems 19%
• Drug Combinations 18%
• Blood-Brain Barrier 17%
• Respiratory Insufficiency 16%
• Nervous System Diseases 16%
• Astrocytes 16%
• Emergencies 13%
• Antioxidants 13%
• Amino Acids 12%
• Pharmacology 11%
• Neurons 10%
• Brain 8%
• Pharmaceutical Preparations 7%
• Therapeutics 5%

Chemical Compounds

• N Methyl Dextro Aspartic Acid Receptor Blocking Agent 79%
• Tirilazad 76%
• Lubeluzole 39%
• Upjohn Dihydroxylation 31%
• Cognitive Enhancer 30%
• Excitatory Amino Acid 25%
• Pharmacologic Agent 25%
• Drug 18%
• Agonist 16%
• Disorder 15%
• Dose 13%
• Antioxidant Agent 13%
• Amount 7%
• Acid 6%